Mohan Jitendra - 06 Feb 2026 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Feb 2026, 18:51:50 UTC
Prior SEC filing
03 Dec 2025
Next SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Philip Mazzara, Attorney-in-Fact

Key filing fact

Mohan Jitendra filed Form 4 for Astera Labs, Inc. (ALAB) on 10 Feb 2026.

Key facts

  • This page summarizes Mohan Jitendra's Form 4 filing for Astera Labs, Inc. (ALAB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Feb 2026, 18:51.

Change

  • Previous filing in this sequence was filed on 03 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001998053 Primary reporting owner

Mohan Jitendra

Relationship
Chief Executive Officer, Director
Address
C/O ASTERA LABS, INC., 2345 NORTH FIRST STREET, SAN JOSE
Signature
/s/ Philip Mazzara, Attorney-in-Fact
Signature date
10 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALAB transaction

Common Stock

Award

Transaction value
$0
Shares
+26,522
Change %
+1.7%
Price
$0.000000
Shares after
1,547,710
Date
06 Feb 2026
Ownership
Direct
Footnotes
F1
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,689,232
Date
06 Feb 2026
Ownership
By Living Trust
Footnotes
F2
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
699,999
Date
06 Feb 2026
Ownership
By Trust
Footnotes
F3
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
700,000
Date
06 Feb 2026
Ownership
By 2021 Trust 1
Footnotes
F4
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
700,000
Date
06 Feb 2026
Ownership
By 2021 Trust 2
Footnotes
F5
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
450,001
Date
06 Feb 2026
Ownership
By 2022 Trust 1
Footnotes
F6
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
450,001
Date
06 Feb 2026
Ownership
By 2022 Trust 2
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

These shares represent an award of restricted stock units ("RSUs") granted on February 6, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F3

These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F4

These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F5

These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F6

These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F7

These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .